Research before 2021
This guide fills the period before the journal research discussed in Journal research map. It distinguishes public ORCID bibliography, publisher metadata/abstracts, and later references to earlier works. These establish different kinds of evidence. A bibliography establishes that a work is recorded, not that its entire text or conclusions have been independently assessed.
English title renderings marked “editorial translation” help readers navigate original-language sources; they are not claims that an English edition was published. Historical regulatory discussion is not current legal or treatment advice.
Early research and book foundations
The record begins with the pharmaceutical-chemistry and legal-pharmacy items documented in History and research foundations, not with the later name Vision 2035. Pharmaceutical law in safe self-medication separately explains the 1998, 2005 and 2010 book lineage and the limits of using historical medicine lists today.
2005: psychological stress and stress-analysis
A 2015 review in the Ukrainian Medical Journal cites a 2005 Kyiv work by Yu. A. Titarenko, E. G. Chuprikova and A. P. Chuprikov: Psychological Stress and Stress-Analysis (editorial translation; original: Психологический стресс и стресс-анализ). This provides an earlier bibliographic connection for Iurii Titarenko and documents that the stress-analysis topic predates his later digital-health publications. The evidence here is the later review's reference, not a direct examination of the 2005 book. No clinical effectiveness or specific intellectual genealogy is inferred.
Source: Ukrainian Medical Journal, 2015 review and bibliography. Page-count variations in secondary records are not resolved here.
2008: regional organization of controlled-medicine licensing
V. O. Shapovalova, L. A. Ukhta and V. V. Shapovalov, Forensic and Pharmaceutical Analysis of Holders of Licences for the Circulation of Controlled Medicinal Products in Ukraine (English rendering of the publisher's title), Pharmaceutical Journal, issue 6 (2008), pp. 41–47.
The publisher abstract describes the distribution of licensed operators handling controlled medicines. It identifies uneven regional concentration and a lack of coordinated placement. The useful connection is between legal authorization and practical geographic access: counting licences alone does not describe whether supply is appropriately distributed. This is historical regulatory-organization research, not a present-day map of licensees.
Evidence: publisher record and abstract, dated 23 December 2008. V. V. Shapovalov's initials are retained because this particular record does not resolve them reliably to one of the two similarly named researchers.
2010: codeine medicines and regulatory categories
V. A. Shapovalova, V. V. Shapovalov and A. V. Peresypkin, Features of the Circulation of Codeine-Containing Medicines in Different Nomenclature-Legal Groups (editorial English rendering), Pharmaceutical Journal 4 (2010), pp. 10–14.
The abstract describes an organizational/legal comparison of codeine medicine categories at that time, including prescription and non-prescription classifications. It helps explain why pharmacology and legal supply status must be considered separately. It must not be taken to imply that codeine is available without prescription today. Its bibliography also cites the 2005 safe-self-medication book and a 2004 good-pharmacy-practice booklet; these are bibliographic references, not full-text examinations of those books.
Evidence: publisher record and abstract. The issue year is 2010; the webpage's 2019 online date is not substituted for it.
2011: addictive disorders and forensic monitoring
V. V. Shapovalov and I. V. Linsky, Forensic Pharmacy: A Study of Predisposition to Addictive Disorders Among Patients with Drug Dependence and Deviant Behaviour (editorial English rendering), Pharmaceutical Journal 6 (2011), pp. 30–34.
The abstract connects the study of addictive disorders and behaviour with forensic monitoring of drug-related offences. Its relevance is to the prevention and analysis of drug-related harm. It should not be read as proof that addiction or an individual's future behaviour can be deterministically predicted.
Evidence: publisher record and abstract. The issue is 2011; the page displays a later 2019 online date. The issue year is used here, without treating that later metadata as the original publication date.
2012: international narcotics control
V. O. Shapovalova, S. M. Mysoev and V. V. Shapovalov, Forensic Pharmacy: Formation of International Narcotics Control in Countering the Drug Threat (editorial English rendering), Pharmaceutical Journal 1 (2012), pp. 28–33.
The abstract discusses the development of international control of narcotic drugs and relates that history to pharmaceutical-law cooperation. It adds an international regulatory strand to the local licensing/access questions. Historical descriptions of a control system should be distinguished from current treaty obligations and domestic implementation.
Evidence: publisher record and abstract. The issue year is 2012 despite a 2019 online date shown on the webpage.
2014: professional duties, access and demand reduction
Professional responsibility and subsidised medicines
Forensic and Pharmaceutical Risks: Inadequate Performance of Professional Duties… discusses barriers to subsidised medicine access for veterans and Chornobyl liquidators. The abstract connects access failures with professional responsibilities and proposes broader accountability under Article 140. That proposal is the authors' historical argument, not a statement of the law currently in force.
The byline contains two V. V. Shapovalov entries, V. O. Shapovalova and O. V. Rogozhnikova. The two V. V. entries have different affiliations and must not be collapsed or assigned fuller names without edition-specific evidence.
Evidence: primary publisher record, DOI 10.21564/2225-6555.2014.2.63579. The shortened English title above is for navigation; use the complete source title in formal citation.
Demand reduction alongside lawful access
V. V. Shapovalov, Forensic and Pharmaceutical Study of Abuse and Development of Principles for Reducing Demand for Psychoactive Substances of Different Classification and Regulatory Groups (editorial English rendering), Pharmaceutical Journal 2 (2014), pp. 39–47.
The abstract describes documentary, legal and comparative analysis of case materials and legislation. It argues for demand reduction while retaining lawful patient access and calls for multidisciplinary evaluation of proposed programmes. This is a useful distinction between controlling misuse and obstructing legitimate treatment.
Evidence: publisher record and abstract. The issue is 2014; a later 2019 webpage date is not used as the original publication date.
2016: oncology, combatants and pharmaceutical provision
Cancer care and regulated medicines
Forensic and Pharmaceutical Study of Violations of the Rules for Medicines Circulation in Pharmaceutical Provision for Cancer Patients (editorial English rendering) compares supply, insurance and reimbursement arrangements and considers oncology prescribing and regulated analgesics. Its proposals include better rural pharmacy access and a wider network of pharmacies authorized to handle narcotic medicines. These are historical proposals, not proof of implementation or a current dispensing guide.
The publisher byline has two V. V. Shapovalov entries, V. A. Shapovalova and O. V. Kulikova; ambiguous initials are preserved. Source: primary record, DOI 10.21564/2225-6555.2016.1.64263.
Medicine provision for servicemen who participated in combat
Andrii Hudzenko, Valentyn Shapovalov, Olha Semenkova, Viktoriia Shapovalova, Valerii Shapovalov and Dariia Moskalenko authored Organization of Pharmaceutical Provision for Servicemen Who Participated in the Fighting Based on Pharmaceutical Law (English rendering), 3(3):20–28.
The abstract describes documentary, legal, questionnaire and forensic methods. It identifies delays in outpatient medicine provision and proposes better coordination between doctor, patient and pharmacist. This makes the link between access, organization and professional duties concrete without implying that a proposed coordination model was proven effective.
Evidence: primary publisher record and abstract, DOI 10.15587/2519-4852.2016.80132. This record supplies distinct ORCIDs for Valentyn Shapovalov, Viktoriia Shapovalova and Valerii Shapovalov, allowing those identities to be linked rather than guessed from initials. The source spelling “Andrii Hudzenko” is retained.
2017: exploratory alcohol-use and qualification survey
Forensic and Pharmaceutical Study of the Presence of a Causal Link Between the Degree of Alcohol Abuse and Qualification Level of the Respondents, Pharmacia 64(3), pp. 31–39, lists V. Shapovalov (Jr.), A. Gudzenko, V. Shapovalova, A. Osyntseva and V. Shapovalov.
The study surveyed 70 clinic respondents using an adapted AUDIT questionnaire and indicators of education and professional experience. The authors report no relationship within the studied respondents and call for deeper research. Despite the causal wording of the title, an exploratory cross-sectional questionnaire does not establish the absence of causation in the wider population. The entry documents the study design, limited finding and collaboration rather than promoting a general clinical conclusion.
Evidence: primary full-text PDF. Initials and the junior designation are preserved as printed; shared names alone are not used to reconstruct contributions.
2020: pandemic-era documentary review
Coronavirus Disease Pandemia 2019: Growth of Epidemic Dangers, Acta Scientific Pharmaceutical Sciences 4(7):61–68, was published on 1 July 2020. The primary abstract describes a documentary and comparative review of SARS, MERS and early COVID-19 literature, combining epidemiological and clinical comparisons with regulatory sources. It documents expansion into pandemic-era public-health questions, not a treatment trial or current therapeutic guidance.
Evidence: publisher abstract and publication date, DOI 10.31080/asps.2020.04.0559. The recorded citation lists V. O. Shapovalova, S. I. Zbrozhek, E. V. Suprun and two V. V. Shapovalov entries; their source byline is preserved rather than expanded by guesswork.
2000–2020: additional public ORCID milestones
The companion ORCID bibliography before 2021 supplies 21 selected records with individual work links and topic-level descriptions. These include medicine quality (2000), registration (2001), pharmacist–physician–patient legal relations (2004), non-prescription controls (2005), safety (2007), disciplinary history (2009), counterfeiting and information systems (2013), rural pharmacy viability (2014), chronic pain (2015), FDA-related comparative regulation (2016), compounding (2017), HIV/AIDS and cancer access (2018), palliative care (2019), and pandemic-era public health (2020).
Their descriptions are explicitly limited to what the bibliographic metadata establishes. A missing full author list is not filled from the identity of the ORCID profile owner.
How these records connect
Across these selected works, recurring questions include the organization of medicines supply, professional duties, access for groups with particular needs, control of psychoactive substances, and the boundary between lawful treatment and misuse. These are documented thematic links to later Medical law, Pharmaceutical law and Medico-pharmaceutical law discussions, not proof that the later project name or every present-day concept existed at the time.
See History and research foundations, Research network, Publications and sources and People and attribution.